Search

Author/Creator Pless, M

1. 1108PCan concomitant diseases predict the compliance with cisplatin plus RT in patients with LA SCCHN? An exploratory endpoint analysis of the COMPLY trial. (23rd October 2018)

Authors:
Dunst, J; Hildebrandt, G; Becker-Schiebe, M; Kuhnt, T; Weykamp, F; Martucci, F; Vordermark, D; Pless, M; Hofmann, D; Bühler, V; Rothschild, S I
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. (30th March 2018)

Authors:
Gramatzki, D; Roth, P; Rushing, E J; Weller, J; Andratschke, N; Hofer, S; Korol, D; Regli, L; Pangalu, A; Pless, M; Oberle, J; Bernays, R; Moch, H; Rohrmann, S; Weller, M
Journal:
Annals of oncology
Issue:
Volume 29:Number 6(2018)
Page Start:
1431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1385PDA randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC: The ETOP and EORTC SPLENDOUR trial. (23rd October 2018)

Authors:
Peters, S; Danson, S J; Hasan, B; Reinmuth, N; Majem, M; Tournoy, K G; Mark, M T; Pless, M; Cobo, M; Rodriguez-Abreu, D; Falchero, L; Massutí, B; Coate, L; von Moos, R; Zielinski, C C; De Maio, E; O'Brien, M; Roschitzki-Voser, H; Dafni, U; Stahel, R A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗